Literature DB >> 29052453

Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.

J A Krooks1, A G Weatherall1,2, P J Holland3.   

Abstract

Approximately half of all patients presenting to dermatologists exhibit signs and symptoms of psychiatric conditions that are either primary or secondary to cutaneous disease. Because patients typically resist psychiatric consult, dermatologists often are on the front line in evaluating and treating these patients. Accordingly, distinguishing the specific underlying or resulting psychiatric condition is essential for effective treatment. The etiology, epidemiology, clinical presentation, diagnosis, and first-line treatment of specific primary psychiatric causes of dermatologic conditions, including delusional infestation, Morgellons syndrome, olfactory reference syndrome, body dysmorphic disorder, excoriation disorder, trichotillomania, and dermatitis artefacta are discussed here, followed by a discussion of the recommended treatment approach with an overview of the different first-line therapies discussed in this review, specifically cognitive behavioral therapy, atypical antipsychotics, selective serotonin reuptake inhibitors, and tricyclic antidepressants. Included is a guide for dermatologists to use while prescribing these medications.

Entities:  

Keywords:  Antipsychotics; antidepressants; psychodermatology

Mesh:

Substances:

Year:  2017        PMID: 29052453     DOI: 10.1080/09546634.2017.1395389

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  2 in total

1.  [Pitfall cryothermic dermatitis artefacta].

Authors:  Mirjana Ziemer; Manfred Kunz; Monica Schüürmann; Daniel Wagenknecht; Konstantin Dumann; Robin Reschke
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

2.  Negative Emotions in Skin Disorders: A Systematic Review.

Authors:  Carmela Mento; Amelia Rizzo; Maria Rosaria Anna Muscatello; Rocco Antonio Zoccali; Antonio Bruno
Journal:  Int J Psychol Res (Medellin)       Date:  2020 Jan-Jul
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.